At Microbio, we’re excited to announce our latest milestone – the appointment of LionDx as our exclusive distributor in Italy. This partnership marks a significant step forward in expanding access to our innovative pathogen diagnostic solutions throughout Europe.
Enhancing healthcare outcomes with InfectID-BSI™
Our flagship product, InfectID-BSI™, is at the core of this partnership. InfectID-BSI™ is a revolutionary molecular diagnostic test that identifies 26 sepsis-causing pathogens directly from blood samples, without the need for enrichment or culture. Utilizing advanced melt curve technology, the test detects the pathogen’s DNA ‘fingerprint’ and provides results in less than three hours. This allows clinicians to rapidly administer targeted treatment, improving patient outcomes through early and accurate diagnosis.
With sepsis being a critical global health concern, especially in hospital settings, we are confident that InfectID-BSI™ can make a meaningful impact on the healthcare landscape in Italy. As a CE-marked product, InfectID-BSI™ offers healthcare providers an essential tool for tackling sepsis, a condition where every minute counts for effective treatment.
About the partnership
Partnering with LionDx, a trusted leader in the distribution of advanced diagnostic solutions, ensures that healthcare providers across Italy will have access to our cutting-edge diagnostic tools. This collaboration underscores our shared commitment to improving patient care through innovation.
Johan Vanderhoeven, Chief Commercial Officer at Microbio, emphasized the importance of this partnership:
We are delighted to start this partnership with LionDx, a company that shares our commitment to innovation and excellence in healthcare. LionDx’s extensive clinical distribution network makes them the ideal partner to bring our diagnostic products to the Italian healthcare market.
Mikkel Johansen, representing LionDx, expressed excitement about this opportunity:
As a distributor of in vitro diagnostics, LionDx has a clear focus on promoting highly innovative products. We are extremely proud to be the exclusive distributor for Microbio in Italy and are ready to offer the unique InfectID-BSI™ test for early detection of sepsis-causing pathogens to Italian patients. The fight against sepsis is crucial, as early diagnosis can save lives and significantly improve clinical outcomes.
Looking ahead
This partnership with LionDx is just the beginning of Microbio’s broader global expansion efforts. By continuing to collaborate with international partners, we aim to make our diagnostic solutions available to healthcare providers worldwide.
Stay tuned for more updates on our growing presence in Europe and beyond as we work to revolutionize the way pathogens are detected and diagnosed.
For more information about our products and this exciting collaboration, visit https://microbio.com.au/infectid-bloodstream-infection/ or liondx.com.